Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen

NCT01978743 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01978743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01978743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
January 31, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv-associated neurocognitive disorder, neurotoxicity